Mankind setting up Rs 300-crore unit to manufacture fertility hormone
Mankind is investing about ₹250-₹300 crore on the Udaipur unit that is expected to begin operations by September-October this year. The unit will manufacture dydrogesterone key starting materials, active pharmaceutical ingredients (API) and formulations.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
